NEWS & MEDIA

Saturday’s Annual Meeting of Shareholders Included Election Results, New Logo, Shareholder Survey Data and Report on 2020 Financial Performance  Sealaska’s 48th annual meeting of shareholders closed Saturday with the announcement of shareholders’ selections to fill the five available seats on the company’s board of directors and the green light for the company to move forward with establishment of a settlement trust.   Three board-endorsed incumbents, Board Chair Joe Nelson (Kaaxúxgu), Barbara Cadiente-Nelson (X’ashk’ugé) and Nicole Hallingstad (Ch’aak’ Tlaa) were re-elected by shareholders. (Nelson and Cadiente-Nelson are not related.) New to the board this year is Liz Medicine Crow (La quen náay), who was selected to run as

Sealaska is deeply grateful for the service of two of its board members who have chosen not to seek another term on the board. These two men have contributed mightily to our company, and their service and commitment to our people has been of incalculable value. Sealaska director Albert Kookesh, formally announced he will not seek another term on the Sealaska Board of Directors. Albert’s term will end at the 2021 annual meeting. Albert has been a member of the

Two of Sealaska’s long-serving directors, Senator Albert Kookesh and Tate London, have decided not to seek another term on the board this year. “Both directors have fulfilled the purpose and mission of Sealaska while serving on behalf of our shareholders,” said Joe Nelson, Sealaska Chair. “We are forever indebted for their service.” The decision by Kookesh and London left two board seats open for new candidates on Sealaska’s team of board-endorsed nominees. La quen náay Liz Medicine Crow and Aan Shawatk’i  Sarah Dybdahl were selected from among nearly 50 highly qualified applicants to